These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25031745)

  • 21. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma.
    Sun L; Wang Y; Shi J; Zhu W; Wang X
    Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of Cks1 protein is associated with lymph node metastasis and poor prognosis in nasopharyngeal carcinoma.
    Xu L; Fan S; Zhao J; Zhou P; Chu S; Luo J; Wen Q; Chen L; Wen S; Wang L; Shi L
    Diagn Pathol; 2017 Jan; 12(1):2. PubMed ID: 28061788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic implication of neuropilin-1 upregulation in human nasopharyngeal carcinoma.
    Xu Y; Li P; Zhang X; Wang J; Gu D; Wang Y
    Diagn Pathol; 2013 Sep; 8():155. PubMed ID: 24053763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
    Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
    Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells.
    Ma L; Deng X; Wu M; Zhang G; Huang J
    FEBS Lett; 2014 May; 588(9):1562-70. PubMed ID: 24613926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
    Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
    Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of clinical parameters and Epstein-Barr virus infection in non-endemic undifferentiated carcinoma of nasopharyngeal type: a Serbian report.
    Terzic TT; Boricic MI; Pendjer IP; Ruzic Zecevic DT; Tomanovic NR; Brasanac DC; Boricic IV
    Med Oncol; 2011 Dec; 28(4):1325-30. PubMed ID: 20446059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.
    Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Tsai CS; Wei YH
    J Clin Oncol; 2001 May; 19(10):2607-15. PubMed ID: 11352952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma.
    Luo J; Wen Q; Li J; Xu L; Chu S; Wang W; Shi L; Xie G; Huang D; Fan S
    Int J Clin Exp Pathol; 2014; 7(9):6117-24. PubMed ID: 25337259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.
    Wang HY; Li YY; Shao Q; Hou JH; Wang F; Cai MB; Zeng YX; Shao JY
    J Transl Med; 2012 Feb; 10():27. PubMed ID: 22321704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Liu N; Cui RX; He QM; Huang BJ; Sun Y; Xie D; Zeng J; Wang HY; Ma J
    Med Oncol; 2013 Mar; 30(1):360. PubMed ID: 23307239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
    Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
    Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma.
    Chen C; Zhou Y; Zhang X; Fu S; Lin Z; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
    Cancer Med; 2020 Mar; 9(5):1721-1732. PubMed ID: 31955525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylated Mnk1 and eIF4E are associated with lymph node metastasis and poor prognosis of nasopharyngeal carcinoma.
    Zheng J; Li J; Xu L; Xie G; Wen Q; Luo J; Li D; Huang D; Fan S
    PLoS One; 2014; 9(2):e89220. PubMed ID: 24551240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.